Eleven neutralizing monoclonal antibodies (MAbs) were produced to the O1BFS 1860/67 strain of foot-and-mouth disease virus (FMDV), and were characterized for their ability to bind viral and subviral antigens in different ELISA tests and to neutralize heterologous type O isolates. Neutralization escape variants of the homologous virus, isolated under pressure from five of these MAbs, were used in crossneutralization tests with all of the 11 antibodies. These studies identified three functionally independent, conformational, neutralizing sites. The most conformationally dependent site bound antibody which neutralized a range of type O virus isolates. A second site was less dependent on conformation and was recognized by antibody that was strain-specific. The least conformational site bound MAbs which showed limited cross-neutralization of other type O strains. This latter site appeared to be immunodominant and contained several overlapping epitopes which showed some differences in their specificities. Isoelectrofocusing and sequencing studies of the variants strongly suggested that polypeptide VP2 contributes to the immunodominant site.
INTRODUCTION
The foot-and-mouth disease viruses (FMDV) constitute the genus aphthovirus in the family Picornaviridae. They occur as seven distinct serotypes within which there is extensive antigenic diversity. The virion consists of one molecule of single-stranded RNA surrounded by 60 copies of each of four structural proteins designated VP1, VP2, VP3 and VP4, of which VP4 is internal. Trypsin treatment of intact 140S particles of type O virus results only in the cleavage of VP1 with a concomitant reduction in infectivity and immunogenicity, indicating that VP1 contains the major immunogenic sites. This was confirmed by the finding that of the four polypeptides only VP 1, in isolation, was capable of eliciting neutralizing antibody (Laporte et al., 1973; Bachrach et al., 1975) . Analysis of fragments of VP1 obtained from chemical and enzymic cleavages (Strohmaier et al., 1982) , together with elucidation of the cDNA-derived primary sequence (Kurz et al., 1981) , located these immunogenic sites within regions 138 to 154 and 200 to 213. Synthetic peptides incorporating these regions were subsequently shown to induce neutralizing responses (Bittle et al., 1982; Pfaff et al., 1982) .
Identification of immunogenic regions on the primary sequence, however, does not provide information on the number and nature of functional sites on the intact virion. A method successfully employed for other picornaviruses has been to raise and characterize neutralizing monoclonal antibodies (MAbs) and to study the patterns of cross-neutralization by these MAbs of variant viruses selected under pressure from individual antibodies. Identification of amino acid substitutions in the primary sequences of these variants has led to the delineation of the 0000-8572 © 1989 SGM antigenic determinants of poliovirus 3 (Minor et al., 1983) , poliovirus 1 (Diamond et al., 1985) and human rhinovirus t4 (Sherry et al., 1986) . These were all shown to form projecting clusters on the virus surface when their molecular structures were resolved by X-ray crystallography (Hogle et al., 1985; Rossmann et al., 1985) . In this communication we have used the same strategy to identify and characterize three independent neutralizing sites on type O FMDV, some of which do not correspond to those previously reported (Stave et al., 1986; Xie et al., 1987) . In the companion paper we describe the mapping of these sites on the primary sequence and show that they all contain components from those regions of VP 1 already shown to be immunogenic .
METHODS
Viruses. All the FMDV strains used were grown in baby hamster kidney (BHK) 21 cells. The virus stocks used for the microneutralization tests were stored as clarified tissue culture harvest material at -20 °C in 50 ~o glycerol. For other immunoassays, virus was purified by the method of Brown & Cartwright (1963) and stored at -70 °C. Some preparations were inactivated with 0-05~ acetylethyleneimine prior to purification.
Cloned virus stocks. OIBFS 1860/67 was cloned using the method described by Parry (1983) . The viruses were plated out on monolayers of BHK-21 cells and overlaid with 0-76 ~o agar containing 150 ~tg/ml DEAE~lextran. A single plaque was isolated and grown as a virus stock. This selection was repeated three times and the final preparation was designated O1BFS 1860 Octl PP3.
Monoclonal antibody-resistant variants. Variants refractory to neutralization by MAbs were isolated using a plaque reduction technique (Minor et al., 1983) . Briefly, BHK-21 cells were grown as monolayers in 9 cm Petri dishes, washed and infected with serial dilutions of O1BFS 1860 Octl PP3 which had been pre-incubated with an equal volume of either undiluted monoclonal antibody or normal serum. Following incubation at 37 °C for 30 min to permit virus attachment, the plates were overlaid with a 0.76~ agar incorporating a 1/50 dilution of either the same MAb or normal serum as appropriate. The plates were maintained at 37 °C for 24 h before the addition of 5 ml of agar overlay containing the vital dye 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride and reincubated for 24 h at 37 °C before plaques were observed and picked. Virus stocks prepared from plaques were assayed using an index test to determine resistance to neutralization. Only mutants fully refractory to the selecting antibody were used for further studies.
Monoclonal antibodies. BALB/c mice or Lou F rats were immunized with purified 01BFS 1860/67 virus particles using a low dose/high dose regime. This involved an initial intraperitoneal inoculation of 2 ~tg of inactivated 140S antigen emulsified in incomplete Freund's adjuvant, foUowed 6 weeks later by an intravenous inoculation of approximately 30 ~tg of infectious 140S particles. Hybridoma cell lines were prepared by fusing mouse spleen cells with either P3-X63-Ag8 or P3-NSI-Ag4-1 myeloma cells, and rat spleen cells with Y3 Ag 1.2.3 myeloma cells, at a ratio of 10:1, using the techniques of McMaster & Williams (1979) and Ouldridge et al., (1984) . The optimum concentration of polyethylene glycol (PEG) (BDH 1540) was predetermined and used at 35 to 50~ (w/v) depending on the batch. Cell hybrid supernatant fluids were screened using an indirect sandwich ELISA technique and an index neutralization test. Colonies from wells containing specific antibody were picked and cloned twice by the terminal dilution technique. Large volume pools of the tissue culture fluids from the monoclonal cell lines were concentrated 10-fold by dialysis against PEG 6000. The concentrates and some ascites fluids (prepared from the earlier fusions) were used for antibody characterization studies. The class of each MAb was ascertained using a commercial gel diffusion isotyping kit (Serotec).
Virus neutralization index tests. These were carried out both as a means of screening for antibody production and for characterizing the MAbs on microtitre plates, using BHK-21 monolayer cells. A range of half-log10 virus dilutions were mixed with a constant dilution (normally 1/10) of either the MAb or negative control fusion material (obtained by fusing the spleen cells of an unimmunized mouse or rat). The virus titres in the presence or absence of specific antibody were compared and the differences expressed as neutralization index values.
Two-dimensional microneutralization tests. These were performed in microtitre plates using BHK-21 cells as the indicator of residual virus infectivity (Rweyemamu et al., 1978) . Doubling dilutions of the MAb preparations were reacted with a range of half-loglo virus dilutions. Antibody titres were calculated from regression analysis of the antibody dilutions required to neutralize 50~o of each virus dose, and expressed as log~0 of the reciprocal dilution of antibody giving 50~ neutralization of 100 tissue culture infective units of virus (lOgl0 SNs0/100 TCIDs0). The relationship of viruses on the basis of their neutralization by each MAb was expressed by the ratio r = (neutralization titre against the heterologous virus)/(neutralization titre against the homologous virus).
The significance of the differences between homologous and heterologous titres was assessed by comparison with critical r values. These were obtained by Student's t-test analysis of a large pool of data (> 3000 tests) and represent the highest values of r that are distinguishable from unity for given numbers of replicate tests and probability (Rweyemamu & Hingley, 1984) .
EL1SA
techniques. An indirect sandwich ELISA was used for identifying antibody-secreting hybridomas. The method has been described previously (Ouldridge et al., 1982) . Briefly, microplates were coated with a preoptimized dilution of rabbit anti-FMDV IgG in carbonate coating buffer. After incubation and washing, 2 ~tg/ml of purified virus particles diluted in Dulbecco's phosphate-buffered saline solution containing 1 ~ (w/v) bovine serum albumin and 0.05 ~ Tween 20 was added. Further incubation at 37 °C for 1 h and washing was followed by the addition of hybridoma supernatant fluids. Finally an anti-species antibody conjugated to horseradish peroxidase was added (1/2000, Miles Laboratories) . The presence of antibody reactive with 140S particles could be detected by colour development on the addition of an orthophenylene diamine/peroxide substrate solution. The colour reaction was stopped with 12.5 ~ (v/v) sulphuric acid and the absorbances were read at 492 nm on a Titertek Multiskan spectrophotometer.
The indirect sandwich technique together with the indirect and competition ELISAs were also used to characterize the MAbs. Essentially the indirect test omitted the first phase capture antibody and the relevant antigen was bound directly to the plate. The competition test is a modification of the indirect sandwich technique in that at the stage of second antibody addition a constant predetermined dilution of the MAb preparation was reacted with serial dilutions of a competitor antigen before adding it to the bound virus particles (1 ~tg/ml) on the test plate. Competition ELISA titres were expressed as the concentration of competitor antigen ~g/ml) required to inhibit 50~o of maximum absorbance development. For both the indirect and sandwich assays the titres were expressed as the reciprocal loglo antibody dilution required to produce 50~ of the absorbance plateau value.
For use in MAb characterization ELISA studies, disrupted virus was prepared by adding 0-014 M-Tris/8 M-urea buffer to purified particles and boiling for 15 min. 12S subunits were obtained by adding 10 ~ of a 1 M-HCI solution and restoring the pH with 10~ 1 M-Tris buffer after 15 rain. Trypsin-treated virus (TTI40S) was prepared by adding a 1 : 1 (w/w) ratio of trypsin and incubating for I h at 37 °C before repurification. All the antigens were used at concentrations equivalent to 2 ~tg/ml of virus particles.
Primer extension sequencing Preparation of virus RNA. BHK-21 cells were infected at a multiplicity of approximately 100 p.f.u./cell with either O~BFS 1860 or MAb-selected variant viruses. After 3 h the infected cells were harvested and virus and viral RNA was purified as described previously (Rowlands et al., 1978) .
Sequencing of viral RNA. Viral RNA was used directly as template for primer extension sequencing reactions as described by Clarke et al. (1987) . Initially a single primer complementary to the 3' side of the structural coding region was used (Rowlands et al., 1983) . Subsequently, synthetic oligonucleotides approximately 300 bases apart were constructed to sequence through the entire structural coding region. These primers were synthesized using an Applied Biosystems machine (model 381A) and cyanoethyl phosphoramidites.
Isoeleetrofocusing. The isoelectrofocusing technique used for this work was that of King & Newman (1980) .
RESULTS

Recognition of viral and subviral antigens
The MAbs were characterized on the basis of their reactions with a number of antigens derived from the homologous virus and with particles of a heterotypic virus (either A2, , Cruzeiro or A 12 119C). The homotypic antigens used were virus particles disrupted to either individual polypeptides or 12S subunits, and trypsin-treated virus. A typical example of the reactivity of a single MAb in all three ELISA systems is shown in Fig. 1 . The patterns of reactivity of all the antibodies in the two ELISA systems in which the test antigens were immobilized are summarized in Table 1 . Some failed to recognize any antigen in the indirect test, namely 14.7.1, 24.31.1 and 70.19.5, but in the case of the latter this may be due to a low titre antibody preparation. All the MAbs except 24.31.1 and 56.1.1 reacted equally well with 140S and TT140S particles in the sandwich test, judged by titre, but lower plateau levels and shallower slopes suggested reduced affinities for TT140S particles (Fig. lb) . None of the MAbs reacted with 12S subunits in the sandwich test although two bound to 12S antigen in the indirect test. The complete lack of reactivity with subunits in the sandwich ELISA may be due to the test system which would require at least two independent binding sites on the antigen for attachment of both capture antibody and MAb. None of the MAbs reacted in either test with virus disrupted to polypeptides. The competition reactions of the same panel of antigens against the MAb preparations are shown in 56.1.1 was specific for native particles. The competition results thus indicate at least three patterns of reactivity with the homotypic antigens. There was no evidence of cross-reactivity with the heterotypic virus particles in any of the test systems.
Cross-neutralization of heterologous virus isolates
The ability of the MAbs to cross-neutralize a number of O strain viruses was tested using the two-dimensional microneutralization assay (Table 3 ). In general, the MAbs recognized strains only of the O1 group of viruses. Two MAbs (14.7.1 and 39.3.4) were strain-specific whereas, in contrast, MAb 24.31.1 recognized most of the O1 strains tested. A third group of MAbs neutralized only some members of the O1 group. Comparison with the reactions of the anti-virus guinea-pig serum showed that together the MAbs display an overall pattern of reactivity that would be expected from a polyclonal preparation. However, two MAbs, 56.1.1 and 24.31.1, showed strong cross-neutralization of 06 VI virus and MAb 64.1.2 neutralized O Thailand 1/80; reactions not evident with polyclonal serum. Presumably these types of antibody are poorly represented within the polyclonal mixture. 
Functional relationships of epitopes
The cross-neutralization, determined from r values, of a number of variant viruses resistant to specific MAbs is summarized in Fig. 2 , demonstrating the functional relationships between individual antibody-binding determinants. MAb 14.7.1 appears to be unique in that it neutralizes all the mutants resistant to the other antibodies; however, the converse experiments were not possible as attempts to obtain variants resistant to this antibody were consistently unsuccessful. By the same criterion, the epitope recognized by MAb 24.31.1 also appears to be a functionally independent site. The ability to neutralize some, but not the entire range of, variants shown by all the remaining MAbs implies that they recognize a single site formed by overlapping epitopes.
Physicochemical analysis of antibody-resistant variant viruses
Primary sequencing and isoelectrofocusing analyses of the structural proteins of parental and MAb escape variant viruses were used in an attempt to identify any mutations that conferred resistance to neutralization. There was no evidence of substitutions in VP3 of any of the viruses tested. The isoelectrofocusing studies revealed similar charge changes in the VP2 of representative isolates of both MAb 53. 103.1 and MAb 70.19.5 variants. Although technical difficulties prevented the clear determination of the nucleotide sequences in some regions of VP2, there appeared to be a unique, non-conservative substitution (K ~ E) at position 134 for seven out of nine mutants analysed. Variants selected under pressure from MAb 24.3l. 1 displayed the same focusing pattern as the parental virus, but sequencing showed that four of the 11 variants analysed had conserved substitutions at amino acid 43 of VP1 (T ~ S or T ~ A) and one had a mutation at amino acid 48 (I ~ V). MAb 56.1.1-selected mutants also possessed focusing patterns indistinguishable from that of the parent, but these were not sequenced.
DISCUSSION
This study of the reactions of a panel of 11 neutralizing MAbs to O1BFS 1860/67 virus with FMDV antigens in different ELISA systems, and their ability to cross-neutralize both other type O isolates and variants of the homologous virus, demonstrates the antigenic complexity of the FMDV particle. The data summarized in Fig. 2 show that there are at least three sites present on the virus. The first site, defined by MAb 14.7.1, appears to be functionally independent of the other two sites in that none of the variants isolated under pressure from the other MAbs were resistant to neutralization by MAb 14.7.1. This is not conclusive, however, because the inability to isolate 14.7.1-resistant variants prevented the reciprocal tests being performed. One possible interpretation of these results is that this antibody preparation may not be monoclonal, but could be a mixture of antibodies recognizing the other two sites. The 14.7.1 antibody, however, was completely strain-specific in neutralization tests, which contrasts with all the other antibodies isolated (Table 3 ). Furthermore, the mapping studies described in the accompanying paper indicate that the binding site of MAb 14.7.1 contains a component that does not contribute to the other sites. It is likely, therefore, that the epitope recognized by MAb 14.7.1 does represent a site independent of the other two that we have identified. This site elicits antibody which recognizes 140S and TT140S antigens in the sandwich ELISA and, additionally, 12S subunits in the competition ELISA. The complete lack of reactivity of 14.7.1 antibody with any of the bound antigens in the indirect ELISA indicates that it recognizes a conformational site which is distorted by adsorption to the solid support.
The reciprocal cross-neutralization of 24.31.1-resistant mutants by all the other MAbs, and of all their resistant variants by 24.31.1 antibody showed that this antibody recognizes a second functionally independent site. The reactions of MAb 24.31.1 with 140S particles in the sandwich ELISA and with both 140S and TT140S antigens, but not with 12S subunits, in the competition ELISA demonstrated that the epitope recognized by MAb 24.31.1 is more dependent on the integrity of the virion than that recognized by 14.7.1, and that trapping TT140S particles with a capture antibody results in particle distortion. The antibody binding to this site possesses broad strain cross-neutralizing ability, effectively neutralizing all the isolates tested that were recognized by polyclonal anti-virion serum plus strain O6VI, which is readily distinguishable by virus antiserum.
The variant cross-neutralization experiments grouped the remaining nine MAbs as binding to a third site containing a series of overlapping epitopes, although epitopes at the limits of the site may not overlap as exemplified by MAbs 64(a). 1 and 53. 103.1. Despite minor variations in the ability of individual antibodies in this group to recognize the different antigens in the ELISA tests, it is evident that, generally, their binding was less dependent on virus conformation than for either the 14.7.1 or 24.31.1 MAbs. The high proportion of antibodies obtained to this site suggests that it is immunodominant on the virus used as the inoculum. There is, however, evidence that at least some of the epitopes within this site are related to the passage history of the virus as they are absent from samples of the homologous virus that have received comparatively few tissue culture passages following isolation from cattle (E. J. Ouldridge, unpublished data). This may partially account for the strain specificities of the MAbs shown in Table 3 , as closely related heterologous viruses have received different numbers of passages.
The three neutralizing sites on O1BFS 1860/67 virus characterized here are all dependent to some extent on virus conformation. Stave et al. (1986) identified two distinct neutralizing sites on the related O1 Brugge strain, one of which was thought to be linear, on the basis of the ability of MAbs recognizing it to react with immobilized peptide, and the other of which was conformational and exhibited similarities to the 24.31.1 site which we describe, although it appeared to be better represented on the 12S subunit. Xie et al. (1987) have recently reported the presence of three neutralizing sites on O1 Switzerland 1965 virus; antibodies recognizing one site bound to immobilized peptide and thus it appeared similar to the linear site of Stave et al. (1986) , the other two were conformation-dependent and poorly represented on the 12S antigen. It is unclear from the data whether either equates to our 24.31.1 site. However, MAbs recognizing each of these sites neutralized O1BFS 1848 virus and do not, therefore, recognize sites with similar specificities to any of our other determinants with the possible exception of the 31.4.1 epitope. The high degree of dependence on the quaternary virus structure displayed by most neutralizing epitopes of type O strains seems to contrast with other serotypes of FMDV. The majority of neutralizing MAbs raised to A22 (Bolwell et aL, 1989) and C (Mateu et aL, 1987) viruses bind to epitopes which can be readily represented by immobilized linear peptides. Despite the conformational nature of the sites, the finding that some of the epitopes are present, in part at least, on 12S subunits isconsistent with a previous report that adsorption of anti-140S particle serum with 12S antigen removes some, but not all, neutralizing activity (Brown & Smale, 1970) . The 12S subunits themselves have also been shown to be capable of stimulating the production of low levels of neutralizing antibody, which was qualitatively different from polyclonal anti-virion antibody (Cartwright et al., 1982) .
In the accompanying paper we describe the mapping of representative epitopes from each of the three sites using peptide reagents in solution . It is clear from this mapping that, although the epitopes recognized by MAb 24.31.1 on one hand and MAbs 53. 103. 1 and 70.19 .5 on the other are functionally independent, they contain components which are very closely juxtaposed on the primary sequence of VP1 in the 143 to 150 region. Conceivably, therefore, epitopes may exist which could span both sites. As this might necessitate the involvement of more amino acids from this region, they would probably be linear in nature. The peptide-binding MAbs already identified may fall into this category (Stave et al., 1986; Xie et al., 1987) . We too have produced a MAb to O1BFS 1860 which binds to an immobilized peptide corresponding to the 141 to 160 region of VP 1, but it possessed only weak neutralizing activity, which was not markedly improved by concentration, and was thus excluded from the site characterization studies. In the context of requiring key antibodies to fully establish the relationship between sites, it is pertinent to note that the epitope recognized by MAb 56.1.1 would have been assigned to a fourth site if the 64(a). 1 antibody alone had not linked it to the dominant group.
The well established fact that synthetic peptides representing the amino acid 141 to 160 sequence of VP 1 of type O viruses can induce high levels of neutralizing antibodies shows that a linear representation of this tract can function as an important determinant on the virus. However, our results suggest that this sequence is normally seen as one component of conformational immunogenic epitopes which also include, or are modulated by, amino acids from other regions of the VP1 protein and VP2.
